ASCRS 2020: OSD improvement in eyes implanted with trabecular meshwork bypass stents


John Berdahl, MD, of Vance Thompson Vision, speaks with Ophthalmology Times'® David Hutton on the highlights of his presentation "Ocular Surface Disease Improvement in Eyes Implanted with Trabecular Meshwork Bypass Stents (iStent or iStent inject)," during the 2020 ASCR virtual meeting.

See more ASCRS coverage

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.